Log In
Or login using:
Sign Up
Or sign up using:
Forgotten Password
Upgrade to a paid membership and never see an advert again!
Why do we display adverts? The advertisements supplied by our carefully selected sponsors enable us to host and support the company data we share with our free members.
Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS
39 COLEHERNE COURT, THE LITTLE BOLTONS, LONDON, SW5 0DN
Unlock Report
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS
Private Limited by guarantee without Share Capital Exempt from using Limited
Active - Accounts Filed
25 August 2009
88990 Other social work activities without accommodation n.e.c. - Other social work activities without accommodation n.e.c.
Available to 28 Jun 2025. Next accounts due by 31 May 2026
Is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Professor Adrian Danek | Director | ||
| Mrs Nicola Jane Keat | Director | ||
| Dr Peter George Mills | Director | ||
| Miss Mary Elizabeth Leigh-Wood | Director | ||
| Mrs Virginia Irvine | Company Secretary | ||
| Ms Virginia Irvine | Director |
Previous Directors & Secretaries
Mortgages and Charges
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £19,827.00 | £38,557.00 | £114,005.00 | £30,895.00 | £112,812.00 |
| Net Worth | £203,426.00 | £197,346.00 | £222,323.00 | £157,215.00 | £212,211.00 |
| Total Current Liabilities | £2,949.00 | £2,188.00 | £1,269.00 | £661.00 | £642.00 |
| Total Current Assets | £206,375.00 | £199,534.00 | £223,592.00 | £157,876.00 | £212,853.00 |
Frequently Asked Questions about ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS
Detailed answers about ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS, including incorporation, status, business activity, and accounts information.
When was ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS founded?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS was officially incorporated on 25 August 2009 and is registered under company number 07000073. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS?
Private Limited by guarantee without Share Capital Exempt from using Limited. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS do?
ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS operates in the following sector: 88990 Other social work activities without accommodation n.e.c. - Other social work activities without accommodation n.e.c. . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS's registered address?
The registered office address of ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS is 39, The Little Boltons, London, Kensington And Chelsea, SW5 0DN. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS financially stable?
Based on the latest accounts up to 28 Jun 2025, ADVOCACY FOR NEUROACANTHOCYTOSIS PATIENTS has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 31 May 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.